BVCF
Overview
BVCF is a Shanghai-based venture capital firm specializing in early-stage investments in life sciences and healthcare sectors across China and the United States. Founded in 2005, BVCF focuses on equity investments in growth-stage companies within the fields of Pharmaceuticals, Biotechnology, Traditional Chinese Medicine, Medical Devices, Healthcare Services, Industrial and Environmental Biotechnology. The firm has raised multiple funds, including BVCF IV, and has made 26 investments, with notable exits such as Oculis, CARsgen Therapeutics, and BioNTech. BVCF's investment strategy emphasizes identifying and nurturing companies with high market potential, disruptive and innovative technologies, and business models. The firm's portfolio includes companies like DiaCarta, which closed an $8 million Series A round for the development and commercialization of precision molecular diagnostics. BVCF's managing partner, Zhi Yang, has over 16 years of China and U.S. life sciences investment experience, with a total of over 20 years in the life sciences industry as a private equity investor, venture capital investor, senior executive, entrepreneur, and scientific inventor. Under his leadership, BVCF has built portfolios of 25 companies, with 8 exits (4 IPOs, 4 acquisitions).
Investment Focus
- High market potential
- Disruptive and innovative technologies
- Strong business models
Portfolio Companies
Reach BVCF directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BVCF
What sectors does BVCF invest in?
BVCF invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Biotechnology and Industrial Biotechnology, and is based in Shanghai, China. BVCF is listed as a venture capital in the ConnectSafely investor database.
What stage does BVCF invest at?
BVCF backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does BVCF invest in?
BVCF invests across United States and China.
What companies has BVCF invested in?
BVCF's portfolio includes CARsgen Therapeutics, BioNTech, Oculis and DiaCarta.
Last updated · Source: ConnectSafely investor database
